drugset / Trial / NCT00878618

Pharmacokinetics of Extended-Release Test- and Reference Formulations of AZD0837

NCT00878618

Phase 1 Completed 36 enrolled AstraZeneca
RandomizedCrossoverOpen-labelBasic science

Summary

The aims of this study are to evaluate the pharmacokinetics, safety and tolerability of the oral doses of the extended-release test- and reference formulations of AZD0837 in healthy volunteers both in fasting and fed conditions.

Timeline

Start
2009-04
Primary completion
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Subject ATECEGATRAN METOXIL Small molecule Oral

Indications

No indication recorded.